Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuro-immunology
When do you offer high-dose vitamin D for patients with multiple sclerosis with normal serum levels?
In light of publication from
Thouvenot et al in JAMA
Related Questions
What is your treatment approach to neuropsychiatric symptoms secondary to lupus?
For patients on anti-CD20 therapy for MS without frequent/opportunistic infections, are there serum IgG levels or ALC levels in which you pause or change therapy due to low levels?
Do you treat tumefactive multiple sclerosis differently than other forms of MS both in the acute and maintenance phase?
How does one interpret an SPEP showing potentially obscured but non-quantifiable M-spike however an IFE showing monoclonal protein?
What baseline visual testing, if any, do you recommend at diagnosis for patients with multiple sclerosis who deny visual complaints?
What therapy do you recommend in situations where IV steroids and IVIg do not help patients with GABA-A encephalitis?
How do you approach the "wearing off" phenomenon for patients with multiple sclerosis on B-cell-depleting therapies?
Are there any precautions that should be taken when transitioning a patient with multiple sclerosis from one disease modifying therapy to another?
What are your vaccine recommendations while patients are on biologics?
At what degree of lymphopenia do you switch/discontinue dimethyl fumarate in patients with multiple sclerosis?